Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activityopen access
- Authors
- Lee, Hanna; Suh, Young Sun; Lee, Sang-Il; Cheon, Yun-Hong; Kim, Mingyo; Noh, Hae Sook; Kim, Hyun-Ok
- Issue Date
- Apr-2022
- Publisher
- BioMed Central
- Keywords
- Rheumatoid arthritis; Disease activity; Insulin-like growth factor-1; Insulin-like growth factor binding protein-3
- Citation
- BMC Research Notes, v.15, no.1
- Indexed
- SCOPUS
ESCI
- Journal Title
- BMC Research Notes
- Volume
- 15
- Number
- 1
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/1398
- DOI
- 10.1186/s13104-022-06008-0
- ISSN
- 1756-0500
1756-0500
- Abstract
- Objective Insulin-like growth factor (IGF)-1 participates in modulating immunity and inflammation. Its bioactivity is controlled by six IGF-binding proteins (IGFBP-1 to IGFBP-6). In particular, the IGFBP-3 level is reportedly linked to the disease activity of rheumatoid arthritis (RA), consistent with our previous study. Therefore, the present study aimed to reproduce the previous results. Results The serum IGFBP-3 level was not significantly different among the three groups according to disease activity based on the DAS28-ESR/CRP (p > 0.05) but was significantly different between the low- and high-disease-activity groups based on the DAS28-CRP (p = 0.036). Meanwhile, the interleukin-6 (IL-6) level moderately correlated with DAS28-CRP (Spearman's rho = 0.583, p < 0.001).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.